Carroll Financial Associates’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q4
$2.34M Buy
17,394
+1,238
+8% +$166K 0.12% 108
2021
Q3
$1.74M Buy
16,156
+189
+1% +$20.4K 0.1% 130
2021
Q2
$1.8M Buy
15,967
+309
+2% +$34.8K 0.1% 127
2021
Q1
$1.69M Sell
15,658
-529
-3% -$57.2K 0.1% 124
2020
Q4
$1.73M Buy
16,187
+509
+3% +$54.5K 0.12% 112
2020
Q3
$1.37M Sell
15,678
-35
-0.2% -$3.07K 0.11% 120
2020
Q2
$1.54M Buy
15,713
+3,676
+31% +$361K 0.13% 103
2020
Q1
$917K Buy
12,037
+273
+2% +$20.8K 0.09% 138
2019
Q4
$1.04M Sell
11,764
-5
-0% -$442 0.08% 136
2019
Q3
$891K Buy
11,769
+477
+4% +$36.1K 0.08% 154
2019
Q2
$821K Buy
11,292
+563
+5% +$40.9K 0.07% 154
2019
Q1
$864K Buy
10,729
+5,885
+121% +$474K 0.08% 137
2018
Q4
$437K Sell
4,844
-249
-5% -$22.5K 0.05% 170
2018
Q3
$481K Buy
5,093
+16
+0.3% +$1.51K 0.05% 175
2018
Q2
$470K Sell
5,077
-833
-14% -$77.1K 0.05% 174
2018
Q1
$559K Sell
5,910
-87
-1% -$8.23K 0.06% 156
2017
Q4
$580K Sell
5,997
-61
-1% -$5.9K 0.06% 155
2017
Q3
$546K Buy
6,058
+46
+0.8% +$4.15K 0.06% 147
2017
Q2
$435K Buy
6,012
+1,573
+35% +$114K 0.05% 173
2017
Q1
$289K Buy
4,439
+35
+0.8% +$2.28K 0.04% 217
2016
Q4
$275K Buy
4,404
+246
+6% +$15.4K 0.04% 206
2016
Q3
$262K Buy
4,158
+247
+6% +$15.6K 0.04% 208
2016
Q2
$242K Sell
3,911
-14
-0.4% -$866 0.04% 210
2016
Q1
$224K Buy
3,925
+711
+22% +$40.6K 0.04% 208
2015
Q4
$190K Buy
3,214
+39
+1% +$2.31K 0.04% 213
2015
Q3
$170K Buy
3,175
+172
+6% +$9.21K 0.04% 213
2015
Q2
$202K Buy
3,003
+811
+37% +$54.6K 0.05% 190
2015
Q1
$128K Sell
2,192
-200
-8% -$11.7K 0.06% 175
2014
Q4
$136K Buy
2,392
+375
+19% +$21.3K 0.09% 142
2014
Q3
$128K Buy
2,017
+975
+94% +$61.9K 0.04% 187
2014
Q2
$59K Buy
1,042
+50
+5% +$2.83K 0.02% 300
2014
Q1
$51K Buy
992
+300
+43% +$15.4K 0.02% 301
2013
Q4
$36K Sell
692
-250
-27% -$13K 0.01% 325
2013
Q3
$42K Sell
942
-100
-10% -$4.46K 0.02% 309
2013
Q2
$43K Buy
+1,042
New +$43K 0.02% 249